celiprolol – Patient Worthy

stevepb / Pixabay

ICYMI: EDSIVO for vEDS Earns Breakthrough Therapy Designation

Post author:Jessica Lynn
Post published:May 20, 2022
Post category:Ehlers Danlos Syndrome Ehlers-Danlos Syndrome

In the United States, the FDA grants Breakthrough Therapy designation to drugs intended to treat serious and life-threatening illnesses, and/or drugs which show significant improvement over available therapies. After receiving…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More